Addenda Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Addenda Capital's RMD Position: Q3 2026 in Review
Addenda Capital reduced its ResMed (RMD) stake by 45% in Q3 2026, selling an estimated $7.66M and leaving 42,604 shares worth $9.42M. The position accounts for 0.25% of the portfolio, ranked #79.
Addenda Capital first reported a position in RMD in Q1 2018 and has held it in 18 quarters since. The position peaked at $21.2M in Q3 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Addenda Capital held 42,604 shares of ResMed worth $9.42M as of Q3 2026.
- Addenda Capital sold 35,103 ResMed shares in Q3 2026, an estimated $7.66M.
- ResMed made up 0.25% of Addenda Capital's portfolio in Q3 2026, its #79 holding.
- Addenda Capital first reported a position in ResMed in Q1 2018 and has held it in 18 quarters since.
- Addenda Capital's ResMed position peaked at $21.2M in Q3 2025.
- 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Addenda Capital's 13F filing for Q3 2026, filed 13 Oct 2026.